Top Tweets for #CVRJax
Dominick Angiolillo and @Aspirinbk join @mmamas1973 to discuss the A-CLOSE trial results, presented yesterday at #ESCCongress in Munich. Watch the video for more on their interpretations of the findings and when to prolong DAPT after high-risk PCI: https://t.co/wbPQKFqc4H
๐ New meta-analysis in #JACC: GLP-1 RAs reduced CV death, MACE & HF risk across 99K+ patients.
โ
Consistent benefits across diabetes, obesity, CKD & HF
โ ๏ธ โ GI & gallbladder events
๐ฏ Personalize therapy by patient profile
Read more in the new issue: https://t.co/7hWeZqRHhk

๐งช๐ Systematic review + collaborative meta-analysis of RCTs in hospitalized #COVID19 pts: 3 trials, n=3,882 statin-naive. Primary outcome = 30-day all-cause death; safety = myopathy, liver enzymes. https://t.co/YdAO49hQpF #CVRjax @bbikdeli @AzitaTalasaz

๐ Big day for #PCSK9i! Sharing our findings on #PCSK9 inhibition and platelet reactivityโIPD meta-analysis with @unibern @inselgruppe @RaberLorenz. #CVRJax #AHA25
๐ง ๐ท Takeaway: Benefits of PCSK9i likely stem from plaque delipidation/stabilizationโnot extra platelet inhibitionโon top of high-intensity statins. Therapeutic focus = atherosclerosis biology, not PRU. #CVRjax https://t.co/wFz4i1I1YC
#CVRjax Thanks to Prof. @CMichaelGibson for discussing the findings of this interesting study assessing the impact of race on platelet reactivity and clinical outcomes after PCI.
Dr. Ortega and Dr. Gibson discuss the intersection of race and platelet function, as well as the disparities in clinical outcomes among different racial groups. @Ortega_Paz @UFHealthJax
DAPT de-escalation and sex, one size fits all donโt apply!
In our latest SRMA (20 RCTs), we found that females are significantly underrepresented and benefit more from DAPT discontinuation, while males benefit more from DAPT de-escalation by switch.
More https://t.co/aDoHnGzmqR

At @UFMedicineJax, weโre not just training future physicians โ weโre shaping the future of health care. With 500+ expert faculty and 39 residency and fellowship programs, we deliver top-tier education that leads to high-quality, compassionate care. https://t.co/VLymvWany5
A Study of Solbinsiran in Participants With Mixed Dyslipidemia - American College of Cardiology โฆ@ACCinTouchโฉ #ACC25 #CVRjax https://t.co/bLD5meUwDs
Late-breaker at #ACC2025: Dr. Joo-Yong Hahn presented the SMART-CHOICE 3 trial, showing superior efficacy and comparable safety of clopidogrel as long-term maintenance monotherapy in high-risk pts compared to aspirin. Slides here: https://t.co/XLZy7c4e6j

#ACC2025: In the SMART CHOICE 3 trial, clopidogrel monotherapy was superior to Aspirin monotherapy in the longstanding phase after PCI due to a reduced risk of myocardial infarction. No difference in bleeding. @FeliceGragnano @PCRonline @ACCinTouch @TCTMD @theheartorg @AHAScience

#20yearsOfEuroIntervention Best documents I have received this year! Happy birthday ๐๐๐ @EuroInterventio @PCRonline @ESC_Journals #CVRJax

Science Behind the Study: Uncoupling Thrombosis and Hemostasis by Inhibiting Factor XI https://t.co/PFU6lOfP7X
#Cardiology

Uncoupling Thrombosis and Hemostasis by Inhibiting Factor XI | New England Journal of Medicine https://t.co/YscTfVdIgB #DJAngiolillo @DFCapodanno @UFHealthJax #CVRjax @NEJM
๐จ #ACC25 Late-Breakers Are Here! ๐จ
๐ 6๏ธโฃ LBCT Sessions
๐ก 5๏ธโฃ Featured Clinical Research Sessions
๐ 2๏ธโฃ Clinical & Investigative Horizons Sessions
๐ 2๏ธโฃ LBCT Deep-Dive Sessions
Check out the full list of groundbreaking trials & secure your spot today! https://t.co/txR0dTQtk1 #JACCJournals

Find out more from the new TITIAN study in #EHJPharmacotherapy: a pairwise and network meta-analysis of anti-inflammatory strategies after myocardial infarction ๐ https://t.co/XImqqdANcp
@EditorEHJCVP @FeliceGragnano @DFCapodanno @LaudaniClaudio

1/3 ๐ง ๐ Switching P2Y12 inhibitors is common in clinical practice for managing acute coronary syndromes & PCI patients. Key strategies focus on balancing ischemic & bleeding risks while addressing drug interactions. Dive into the evidence! ๐ #CVRJax https://t.co/OK4pYN5sLW
@NEJM Based on the Popular pause TAVI, what you will do in clinical practice with OAC in patients undergoing TAVR/TAVI @PCRonline @ESC_Journals @EuroInterventio #ESCCongress #CVRjax
Last Seen Hashtags on Sotwe
เธฃเธฑเธเธเธฒเธเธเธฃเธฒเธชเธฒเธ
Seen from Thailand
Teenageee
Seen from France
gangbang #wife
Seen from Thailand
mgai(((((())))))****** video
Seen from Pakistan
ไบงๅๅฆๅฆ
Seen from Spain
mzansihomemade
Seen from South Africa
Femdom
Seen from United States
snapchat
Seen from Singapore
ensestpaylasฤฑm
Seen from Turkey
bursatravesti
Seen from Turkey
Trends for you
Most Popular Users

Elon Musk 
@elonmusk
241M followers

Barack Obama 
@barackobama
118.8M followers

Cristiano Ronaldo 
@cristiano
114.5M followers

Donald J. Trump 
@realdonaldtrump
111.9M followers

Narendra Modi 
@narendramodi
107M followers

Rihanna 
@rihanna
98.7M followers

NASA 
@nasa
92.2M followers

Justin Bieber 
@justinbieber
91.8M followers

KATY PERRY 
@katyperry
90M followers

Taylor Swift 
@taylorswift13
84M followers

Lady Gaga 
@ladygaga
75.5M followers

Virat Kohli 
@imvkohli
73.4M followers

Kim Kardashian 
@kimkardashian
70.8M followers

YouTube 
@youtube
68.7M followers

Neymar Jr 
@neymarjr
66.4M followers

Bill Gates 
@billgates
65.2M followers

Selena Gomez 
@selenagomez
63.1M followers

The Ellen Show
@theellenshow
62.2M followers

CNN 
@cnn
61.7M followers

X 
@x
60.6M followers

















